Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.

Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.

Item
http://www.wikidata.org/entity/Q54334801
Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysisMalate dehydrogenase-2 inhibitor LW6 promotes metabolic adaptations and reduces proliferation and apoptosis in activated human T-cells.Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathwayAngiogenin is upregulated during the alloreactive immune response and has no effect on the T-cell expansion phase, whereas it affects the contraction phase by inhibiting CD4+ T-cell apoptosis.Chemical Components from Aloe and their Inhibition of Indoleamine 2, 3-dioxygenase.Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment.Modulation of cancer-specific immune responses by amino acid degrading enzymes.Preconditioning of primary human renal proximal tubular epithelial cells without tryptophan increases survival under hypoxia by inducing autophagy.Tryptophan depletion under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through reactive oxygen species-dependent and independent pathways.Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathways.In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity.The role of indoleamine-2,3-dioxygenase in normal and pathological pregnancies.Indoleamine 2,3-dioxygenase in psoriasis: a defective mechanism.LW106, A Novel Inhibitor of IDO1, Suppresses Tumor Progression by Limiting Stroma-Immune Crosstalk and Cancer Stem Cell Enrichment in the Tumor Microenvironment.Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?
P2860

Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.

Item
http://www.wikidata.org/entity/Q54334801
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Indoleamine 2,3-dioxygenase in ...... glycolysis and proliferation.
@en
Indoleamine 2,3-dioxygenase in ...... glycolysis and proliferation.
@nl
type
label
Indoleamine 2,3-dioxygenase in ...... glycolysis and proliferation.
@en
Indoleamine 2,3-dioxygenase in ...... glycolysis and proliferation.
@nl
prefLabel
Indoleamine 2,3-dioxygenase in ...... glycolysis and proliferation.
@en
Indoleamine 2,3-dioxygenase in ...... glycolysis and proliferation.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Indoleamine 2,3-dioxygenase in ...... , glycolysis and proliferation
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698